Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Revefenacin in Acute Respiratory Insufficiency in COPD (RARICO)

NCT04315558 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT04315558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04315558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Revefenacin in Acute Respiratory Insufficiency in COPD (RARICO)
Lead sponsor
University of California, Los Angeles
Phase
Phase 2
Overall status
Completed
Start date
November 1, 2020
Completion date
January 1, 2025
Enrollment
21 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory failure, copd